News

XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right

Detailed price information for Xoma Royalty Corporation (XOMA-Q) from The Globe and Mail including charting and trades.

Scenic road trips across the US for breathtaking views and memorable adventures

These scenic road trips across America offer volcanoes, national parks, oceans, lakes, historic towns, and wildlife views, ...